We’re pleased to announce today that Dr. Darlene Walley, an expert with over 30 years of executive experience in life sciences, has been named the CEO of Plan A™ and that Peter Barton Hutt, former Chief Counsel to the FDA, has joined the Advisory Board for NEXT Life Sciences.

“We are thrilled to bring Dr. Walley on as the CEO of Plan A™ with her extensive background, expertise in biotech and pharma, and passion for bringing transformative products to market.” said L.R. Fox who will remain CEO of parent company NEXT Life Sciences, “I am also

We're honored to have the announcement of new Plan A CEO Dr. Darlene Walley celebrated and featured in FORTUNE MPW Daily with Emma Hinchliffe!

FORTUNE Emma Hinchliffe MPW Daily is the premier newsletter featuring the world’s most powerful women in business and leadership. Our team is beyond excited to have Dr. Walley leading our team as a true mover and shaker in the healthcare space. Join us again in celebrating Dr. Walley!

StartUp Health company NEXT Life Sciences, the maker of the male contraceptive Plan A™, has appointed Dr. Darlene R. Walley as the CEO of Plan A™ to spearhead and bring to market male birth control options. #HealthTransformer #HealthMoonshot ow.ly/LGy750TUTiB

In a new piece from FORTUNE - Nina Ajemian interviewed Plan A CEO, Dr. Darlene Walley as well as Male Contraceptive Initiative Executive Director, Heather Vahdat on their perspectives as the world prepares for a second Trump administration while male birth control options also

FORTUNE Male Contraceptive Initiative “We’re in a time of transition, and the time is right for male contraception to really move out and get onto the market,” said MCI's Heather Vahdat. NEXT Life Sciences Dr. Darlene Walley continues, “We’re hoping that by giving the other half of the population the ability to

Today we are pleased to announce the promotion of Dr. Darlene Walley as the new CEO of NEXT Life Sciences! In addition, NEXT Life Sciences is also celebrating the joining of Dr Robert Dudley, founder and inventor of men’s health product AndroGel®, as our Chief Development

L.R. Fox shares: “Dr. Walley has already had incredible success in securing a clear pathway for Plan A with the FDA and it made sense for her to lead the entire organization to get our portfolio of products to market... Dr. Walley is known for her tremendous success as an

StartUp Health company NEXT Life Sciences named Dr. Darlene Walley as CEO! Founder L.R. Fox will remain Executive Chairman to support the team, ensuring the right resources & setting long-term vision. ➡️ ow.ly/rjlC50UyXCG #HealthTransformer #HealthMoonshot

This week on Healthcare Strategies, Dr. Darlene Walley, CEO of NEXT Life Sciences, sat down with Alivia Kaylor to introduce Plan A — our reversible on-demand, long-acting male contraceptive in development - aiming for a 2027 launch. pharmanewsintel

pharmanewsintel 🔑 Key Highlights from the Discussion: - Flexible & Reversible: Blocks sperm with Vasalgel®, reversible in minutes. - High Demand: Vasectomy requests have spiked 1000% post-Roe v. Wade. - Affordable Access: Without insurance, the cost could approximate $8/month over 10 years,

pharmanewsintel With 85% of men aged 18-45 seeking new options, Plan A™ is poised to transform reproductive health for both men and women - balancing reproductive responsibility - and reshape the idea of family planning worldwide. 🌍 #MaleContraception #ReproductiveHealth #HealthcareInnovation

Last week, Erin Brodwin from Axios sat down for an exclusive interview with CEO Dr. Darlene Walley, where we were excited to announce that @NEXTLifeScience is now raising a $20M Series A to bring Plan A — a male birth control option designed to be reversible and

Erin Brodwin Axios NEXT Life Sciences With clinical trials kicking off in Australia this month and more plans for Canada in 2025, NEXT Life Sciences is now targeting a potential FDA submission in 2027 — a milestone that would make Plan A™ a game-changer for male contraception. 🔗 Read the full story on Axios:

This isn’t just a bold innovation—this is the future of reproductive health. Black Sheep Capital Partners is proud to be an early investor in NEXT Life Sciences , a company reshaping what male birth control could look like with Plan A. Imagine a world where men have a simple,

“It’s like giving men a remote control for their choices.” A great description from Myles Sabiniano of Xraised - summing up what we’re developing with Plan A

Our CEO, Dr. Darlene Walley, sat down with Myles to break down how Plan A is flipping the script on birth control — with long-acting, reversible male contraception. xraised.com/videos/revolut…

We’re proud to welcome Peter Barton Hutt, former Chief Counsel to the FDA and a pioneer of modern food and drug regulation, to the Advisory Board of NEXT Life Sciences. Peter shaped the FDA’s medical device guidance that continues to set the standard today. His expertise will be

Plan A is working toward a new era of male contraception, creating options that expand choice and reshape how couples approach family planning and sexual health. planaformen.com/posts/peter-ba…